CD8+ Cell Density Gradient across the Tumor Epithelium-Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy.
Julius DrachnerisAllan RasmussonMindaugas MorkunasMantas FabijonaviciusAlbertas CekauskasFeliksas JankeviciusArvydas LaurinaviciusPublished in: Cancers (2023)
We found that gradient indicators of CD8+ cell densities across the tumor epithelium-stroma interface, along with routine clinical and pathology data, improve the prediction of RFS in NMIPUC.